Emmaus Medical
  • CEO Letters
  • Overview
    • Mission
    • Leadership
      • Management Team
      • Board of Directors
    • Corporate Compliance
    • Corporate Governance
  • Products
    • Endari
  • Pipeline
    • Research Publications
    • Diverticulosis
    • Cell Sheet Engineering
  • News
    • Press Releases
    • Media Contacts
    • Media Kit
  • Investors
  • Career
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Pre-merger Emmaus Life Science SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Dr. Niihara Meets with Local Indian Governor

Dec 20, 2022 10:00am EST

Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari®

Dec 19, 2022 10:00am EST

Endari® Receives Kuwaiti Marketing Authorization

Dec 07, 2022 2:25pm EST

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Qatar Ministry of Public Health

Nov 17, 2022 9:30am EST

/C O R R E C T I O N -- Emmaus Life Sciences, Inc./

Nov 14, 2022 6:17pm EST

Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari®

Sep 28, 2022 6:30am EDT

Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update

Aug 15, 2022 4:30pm EDT

Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor

Jul 12, 2022 10:00am EDT

Life Sciences Investor Forum: Company Executives Present Live June 23rd

Jun 21, 2022 9:53pm EDT

Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update

May 13, 2022 8:23am EDT
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...15
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Emmaus Medical, Inc. Registered ® Emmaus Medical, Inc, Torrance, CA. All rights reserved.

  • Privacy
  • Terms of Use
  • Contact